https://openbell.ai/ 2026-10-20T17:44:00.889Z hourly 1.0 https://openbell.ai/support 2026-10-20T17:44:00.889Z monthly 0.7 https://openbell.ai/privacy 2026-10-20T17:44:00.889Z monthly 0.5 https://openbell.ai/terms 2026-10-20T17:44:00.889Z monthly 0.5 https://openbell.ai/feed.json 2026-10-20T17:44:00.889Z hourly 0.8 https://openbell.ai/news/ABBV:1792518103088 2026-10-20T17:41:43.088Z daily 0.9 https://cdn.brandfetch.io/ABBV/w/400/h/400?c=1idopYfmtR7ZKg8QMud AbbVie shares are trading higher after Health Canada approved SKYRIZI for pediatric plaque psoriasis patients and the company announced a multiyear partnership with the McLaren Mastercard Formula 1 Team. openbell Financial News https://openbell.ai/news/TRI:1792517743295 2026-10-20T17:35:43.295Z daily 0.9 https://cdn.brandfetch.io/TRI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Thomson Reuters shares are trading higher after Jefferies initiated coverage on the stock with a Buy rating and announced a $130 price target. openbell Financial News https://openbell.ai/news/GOOG:1792517715618 2026-10-20T17:35:15.618Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/Mountain-View--Ca--Usa---May-1--2022-Goo.jpg?width=250&height=187 Alphabet Earnings Ahead: Cloud Growth, Gemini, TPU Sales Could Drive Upside Alphabet Inc (NASDAQ: GOOG) is set to report its third-quarter earnings on October 28, with expected revenue of $111.4 billion and GAAP earnings of $3.07 per share, surpassing analyst expectations. The company's Cloud segment is projected to grow by 93%, exceeding the consensus estimate of 89%. However, Alphabet faces headwinds including legal charges and costs associated with SpaceX. Currently, Alphabet shares are trading at $337.63, down 0.74%. https://openbell.ai/news/NFLX:1792517379762 2026-10-20T17:29:39.762Z daily 0.9 https://cdn.brandfetch.io/NFLX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Netflix Ads Suite Has Better Buying, Better Planning, Better Results; Plans To Expand Ads To 15 New Countries Netflix announced enhancements to its advertising suite, which include improved buying, planning, and results for advertisers. The company plans to expand its advertising services to 15 new countries, aiming to increase its market presence and revenue from ad sales. This strategic move reflects Netflix's ongoing efforts to diversify its revenue streams beyond subscription services. https://openbell.ai/news/HNGE:1792517349783 2026-10-20T17:29:09.783Z daily 0.9 https://cdn.brandfetch.io/HNGE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching Hinge Health; Shares See Volume To The Upside, Hearing Investor Business Daily SwingTrader Buys Stock openbell Financial News https://openbell.ai/news/LION:1792517300124 2026-10-20T17:28:20.124Z daily 0.9 https://cdn.brandfetch.io/LION/w/400/h/400?c=1idopYfmtR7ZKg8QMud Lionsgate Studios shares are trading higher following a report suggesting that Legendary Entertainment has revived talks to acquire the company and submitted a takeover offer. openbell Financial News https://openbell.ai/news/TRI:1792517287949 2026-10-20T17:28:07.949Z daily 0.9 https://cdn.brandfetch.io/TRI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Jefferies Initiates Coverage On Thomson Reuters with Buy Rating, Announces Price Target of $130 Jefferies analyst Surinder Thind has initiated coverage on Thomson Reuters (NASDAQ: TRI) with a Buy rating. The firm has set a price target of $130 for the company's stock. https://openbell.ai/news/AZN:1792517218608 2026-10-20T17:26:58.608Z daily 0.9 https://cdn.brandfetch.io/AZN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Oracle Joins Forces With AstraZeneca to Put AI to Work in Drug Research Oracle Corp. (NYSE: ORCL) has entered a nonbinding agreement with AstraZeneca Plc (NYSE: AZN) to leverage artificial intelligence and real-world data for enhancing clinical-trial recruitment and connecting research with patient care. The collaboration aims to identify eligible patients more quickly and improve evidence generation, focusing on areas such as oncology and rare diseases. During premarket trading, AstraZeneca shares rose by 1.82% to $166.93, while Oracle shares fell by 1.61% to $127.51. https://openbell.ai/news/GPC:1792517214460 2026-10-20T17:26:54.460Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/Konskie--Poland---January-25--2024-Genui.jpg?width=250&height=187 Genuine Parts Slashes 2026 Profit Outlook, Stock Falls Genuine Parts Co. (NYSE: GPC) reported mixed third-quarter results, with adjusted earnings of $2.07 per share surpassing analyst estimates of $2.05, while revenue of $6.521 billion fell short of expectations of $6.523 billion. The company lowered its 2026 GAAP earnings forecast to $5.60-$5.85 per share, down from $5.90-$6.40, and narrowed its adjusted earnings forecast to $7.50-$7.75 per share. Following the announcement, GPC's stock dropped 6.28% to $122.00 in premarket trading. https://openbell.ai/news/GPC:1792517200517 2026-10-20T17:26:40.517Z daily 0.9 https://cdn.brandfetch.io/GPC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Genuine Parts Slashes 2026 Profit Outlook, Stock Falls Genuine Parts Co. reported third-quarter adjusted earnings of $2.07 per share, exceeding analyst expectations of $2.05, but revenue of $6.521 billion fell short of the $6.523 billion forecast. The company lowered its 2026 GAAP earnings outlook to $5.60-$5.85 per share, down from $5.90-$6.40, and below the analyst estimate of $6.78. Despite these adjustments, Genuine Parts maintained its full-year sales growth outlook of 3% to 5.5% and reaffirmed its operating cash flow forecast of $1 billion to $1.2 billion. Following the news, GPC stock fell 6.28% to $122.00 in premarket trading. https://openbell.ai/news/AZN:1792517197448 2026-10-20T17:26:37.448Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/Konskie--Poland---November-13--2024-Orac.jpg?width=250&height=187 Oracle Joins Forces With AstraZeneca to Put AI to Work in Drug Research Oracle Corp. has entered a nonbinding agreement with AstraZeneca Plc to leverage artificial intelligence and real-world data for improving clinical-trial recruitment and connecting research findings with everyday care. The collaboration aims to expedite patient eligibility identification, expand trial access, and enhance evidence generation, focusing on areas such as oncology and cardiovascular diseases. In premarket trading, AstraZeneca shares rose by 1.82% to $166.93, while Oracle shares fell by 1.61% to $127.51. https://openbell.ai/news/AAL:1792517131183 2026-10-20T17:25:31.183Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/American-Airlines.jpg?width=250&height=187 Why Is American Airlines Stock Surging Tuesday? American Airlines Group Inc. (NASDAQ: AAL) saw its stock surge 4.44% to $12.20 on Tuesday, driven by a 1% drop in crude oil prices, which fell below $97 per barrel, easing fuel cost pressures for airlines. The positive sentiment was further bolstered by GE Aerospace's strong third-quarter results, reporting adjusted earnings of $2.25 per share on revenue of $13.285 billion, exceeding Wall Street estimates. American Airlines is set to report its third-quarter results on October 22, with expectations of a loss of 36 cents per share and revenue projected to rise to $16.21 billion from $13.69 billion. https://openbell.ai/news/NOW:1792516853541 2026-10-20T17:20:53.541Z daily 0.9 https://cdn.brandfetch.io/NOW/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of software companies are trading higher as the sector rebounds from recent weakness. Also, recent economic data raised expectations that the Fed will skip interest rate hikes this month. openbell Financial News https://openbell.ai/news/HTFL:1792516844832 2026-10-20T17:20:44.832Z daily 0.9 https://cdn.brandfetch.io/HTFL/w/400/h/400?c=1idopYfmtR7ZKg8QMud HeartFlow shares are trading higher after Piper Sandler raised its price target on the stock from $45 to $64. openbell Financial News https://openbell.ai/news/INTR:1792516645256 2026-10-20T17:17:25.256Z daily 0.9 https://cdn.brandfetch.io/INTR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Inter & Co shares are trading higher after the company announced Banco Inter will acquire the remaining 39.75% stake in Inter Seguros, giving it full ownership of the insurance unit. Additionally, UBS raised its price target on the stock from $8.8 to $10. openbell Financial News https://openbell.ai/news/META:1792516578709 2026-10-20T17:16:18.709Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/Meta-Muse.jpg?width=250&height=187 Meta Q3 Preview: Muse Put Company in Spotlight, Will Financials Support a Rally? Meta Platforms (NASDAQ: META) is set to report its Q3 financial results, with analysts predicting revenue of $63.36 billion, up from $51.24 billion a year ago. However, earnings per share are expected to decline to $5.89 from $7.25. The company has a history of exceeding revenue estimates for over 10 consecutive quarters, although it missed earnings estimates in the last quarter. Meta's stock is currently down 1.7% at $693.23, with a year-to-date increase of 6.5%. https://openbell.ai/news/ATNM:1792516264367 2026-10-20T17:11:04.367Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/Doctors-Are-Counseling-Prostate-Cancer-P.jpg?width=250&height=187 Why Is Actinium Pharmaceuticals Stock Gaining Tuesday? Actinium Pharmaceuticals Inc. (NYSE: ATNM) reported positive initial clinical results from its Phase 1 study of ATNM-400 for metastatic castration-resistant prostate cancer, leading to an 8.85% increase in stock price to $1.43. The study demonstrated a favorable safety profile with no dose-limiting toxicities observed in the initial cohort of patients. Trading volume surged to 670,435 shares, significantly above the 100-day average of 150,386 shares, indicating heightened investor interest. https://openbell.ai/news/RCL:1792515966351 2026-10-20T17:06:06.351Z daily 0.9 https://cdn.brandfetch.io/RCL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of cruise companies are trading higher amid declining oil prices. openbell Financial News https://openbell.ai/news/NCPL:1792515947393 2026-10-20T17:05:47.393Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=250&height=187 12 Financials Stocks Moving In Tuesday's Intraday Session During Tuesday's intraday session, Netcapital (NASDAQ: NCPL) shares surged by 29.9% to $2.12, with a market value of $12.7 million. Other notable gainers included Cheche Group (NASDAQ: CCG) up 24.83% to $5.74, and Huize Holding (NASDAQ: HUIZ) rising 24.38% to $2.45. Conversely, Solowin Holdings (NASDAQ: AXG) saw a significant decline of 23.7%, dropping to $0.09, while Donegal Group (NASDAQ: DGICB) fell by 11.63% to $17.41. https://openbell.ai/news/MYGN:1792515947197 2026-10-20T17:05:47.197Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&height=187 12 Health Care Stocks Moving In Tuesday's Intraday Session On Tuesday, Myriad Genetics (NASDAQ: MYGN) saw its stock price increase by 36.85% to $5.76, with a market capitalization of $397.6 million. Other notable gainers included SCWorx, which rose 42.9% to $3.83, and Anbio Biotechnology, which increased by 22.32% to $4.0. In contrast, China SXT Pharmaceuticals experienced a significant decline of 41.5%, dropping to $0.07. https://openbell.ai/news/GOW:1792515946976 2026-10-20T17:05:46.976Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Industrials Stocks Moving In Tuesday's Intraday Session On Tuesday, GOWell Energy Technology (NASDAQ: GOW) saw a significant increase in its stock price, rising 27.6% to $3.98, with a market value of $145.8 million. Other notable gainers included Nixxy (NASDAQ: NIXX) which rose 16.97% to $0.27, and Roma Green Finance (NASDAQ: ROMA) which increased by 15.9% to $8.6. Conversely, Callan Jmb (NASDAQ: CJMB) experienced a sharp decline of 55.6%, falling to $0.85, while FreightCar America (NASDAQ: RAIL) dropped 33.42% to $3.9. https://openbell.ai/news/BRZE:1792515946736 2026-10-20T17:05:46.736Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=250&height=187 12 Information Technology Stocks Moving In Tuesday's Intraday Session On Tuesday, Braze (NASDAQ: BRZE) saw a significant stock increase of 51.5%, reaching $45.51, with a market capitalization of $3.4 billion. Other notable gainers included Gen Digital Inc. (NASDAQ: GENVR) with a 44.23% rise to $1.5, and Peraso (NASDAQ: PRSO) which increased by 43.7% to $0.55, having a market cap of $5.8 million. Conversely, ChowChow Cloud Intl (AMEX: CHOW) experienced a decline of 13.2% to $0.29, while Tower Semiconductor (NASDAQ: TSEM) fell by 10.15% to $179.98, with a market cap of $22.7 billion. https://openbell.ai/news/BB:1792515941977 2026-10-20T17:05:41.977Z daily 0.9 https://cdn.brandfetch.io/BB/w/400/h/400?c=1idopYfmtR7ZKg8QMud BlackBerry shares are trading higher after the company announced its QNX division royalty backlog exceeded $1.2 billion, increasing by more than $250 million in two quarters. openbell Financial News https://openbell.ai/news/BRZE:1792515785652 2026-10-20T17:03:05.652Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/Braze-Photo-by-T--Schneider-via-Shutters.jpg?width=250&height=187 Why Is Braze Stock Surging on Tuesday? Braze, Inc. (NASDAQ: BRZE) shares surged approximately 50.90% to $45.33 following the announcement of its acquisition by Salesforce, Inc. (NYSE: CRM) for about $5.66 billion in enterprise value. Under the deal, Braze Class A shareholders will receive $47.50 per share in cash, reflecting a 58% premium over the previous closing price of $30.04. The transaction is expected to close in Salesforce's fiscal year 2028, pending shareholder and regulatory approvals. https://openbell.ai/news/META:1792515758407 2026-10-20T17:02:38.407Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/Meta-Platforms-Inc.jpg?width=250&height=187 Meta Heads Into Earnings With AI Ambitions Soaring, Cash Burn in Focus Meta Platforms Inc. is set to release its third-quarter 2026 earnings report on October 21, with analysts projecting earnings of $5.89 per share and revenue of $63.36 billion, up from $51.24 billion a year earlier. Analysts from Rosenblatt and Citizens JMP Securities maintain bullish ratings with price targets of $886 and $885, respectively, citing strong advertising growth and the potential of the Muse AI agent. However, significant investments in AI are expected to pressure free cash flow, with capital spending projected between $130 billion to $145 billion in 2026. As of the latest data, Meta's shares were down 1.96% at $691.60. https://openbell.ai/news/RVMD:1792515617287 2026-10-20T17:00:17.287Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/Lung-cancer.jpg?width=250&height=187 Revolution Medicines Begins Phase 3 Trial For Advanced Lung Cancer Treatment Revolution Medicines Inc. (NASDAQ: RVMD) has initiated a global Phase 3 clinical trial, RASolve 308, to evaluate its investigational therapy zoldonrasib in combination with standard care for metastatic lung cancer patients with the RAS G12D mutation. The trial's primary endpoint is progression-free survival, while secondary endpoints include overall survival and safety. As of the article's publication, Revolution Medicines shares increased by 6.90% to $194.71. https://openbell.ai/news/GM:1792515534076 2026-10-20T16:58:54.076Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/Stock-Financial-Index-Show-Successful-In.jpg?width=250&height=187 Health Care Stocks Hit Record Highs, GM Drops Nearly 8%: Stock Market Today Health care stocks reached record highs, with the Health Care Select Sector SPDR Fund climbing 2.2%. General Motors Co. (NYSE: GM) experienced a significant decline of 7.6%, marking its worst day since July 2025, despite reporting third-quarter adjusted EPS of $3.70, which exceeded estimates. The company's revenue of $50 billion also surpassed forecasts, but its full-year EPS guidance of $12.75-$13.75 fell short of the analysts' $13.41 midpoint. Overall, the S&P 500 rose 0.3% to 7,713, while the Dow Jones increased by 0.9% to 52,424. https://openbell.ai/news/MHVIY:1792515533434 2026-10-20T16:58:53.434Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/Japan-flag.png?width=250&height=187 Mitsubishi Heavy Industries’ Investment Case—2026 Earnings Set the Stage Mitsubishi Heavy Industries Ltd. reported a strong fiscal 2026 performance, with revenue increasing by 14.1% to ¥4.97 trillion and business-activity profit rising 21.8% to ¥432.2 billion. The company's diverse operations across defense, energy, aerospace, and infrastructure position it well to capitalize on Japan's strategic investment priorities. However, the sustainability of its growth will depend on effective project execution, margin management, and cash flow conversion amid potential risks such as project delays and government budget changes. https://openbell.ai/news/DFH:1792515468492 2026-10-20T16:57:48.492Z daily 0.9 https://cdn.brandfetch.io/DFH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Dream Finders Homes shares are trading higher after the company announced the completion of its acquisition of Beazer Homes USA in an all-cash transaction with an enterprise value of ~$2.2 billion. openbell Financial News https://openbell.ai/news/TW:1792515361442 2026-10-20T16:56:01.442Z daily 0.9 https://cdn.brandfetch.io/TW/w/400/h/400?c=1idopYfmtR7ZKg8QMud Tradeweb Markets shares are trading higher after the company announced that it has entered into a definitive agreement to acquire Trumid Holdings for a purchase price of approximately $1.97 billion. openbell Financial News https://openbell.ai/news/LION:1792515196643 2026-10-20T16:53:16.643Z daily 0.9 https://cdn.brandfetch.io/LION/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Legendary Revives Lionsgate Takeover Talks, Submits Offer' - Bloomberg Legendary has revived discussions regarding a takeover of Lionsgate and has submitted a formal offer. This move comes as part of ongoing negotiations between the two companies. The stock ticker for Lionsgate is LION. https://openbell.ai/news/SLDB:1792515171600 2026-10-20T16:52:51.600Z daily 0.9 https://cdn.brandfetch.io/SLDB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Solid Biosciences shares are trading higher after the company announced multiple presentations at the ESGCT Annual Congress showcasing its SGT-003 gene therapy program and proprietary POLARIS-101 capsid platform. openbell Financial News https://openbell.ai/news/IT:1792515148381 2026-10-20T16:52:28.381Z daily 0.9 https://cdn.brandfetch.io/IT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Gartner shares are trading higher after both Wells Fargo and Truist Securities raised their respective price targets on the stock. openbell Financial News https://openbell.ai/news/AMGN:1792515094219 2026-10-20T16:51:34.219Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/Warsaw--Poland---January-20--2024-Astraz.jpg?width=250&height=187 AstraZeneca/Amgen Drug Shows Significant Remission in Eosinophilic Esophagitis Study AstraZeneca and Amgen announced positive results from the Phase 3 CROSSING trial of Tezspire (tezepelumab) for treating eosinophilic esophagitis, showing histologic remission rates of 64.8% and 68.9% for the 210mg and 420mg doses, respectively, at week 24, compared to 3.5% for placebo. The drug also demonstrated significant reductions in dysphagia symptoms and maintained efficacy through week 52. Following the announcement, AstraZeneca's shares rose by 2.74% to $168.44, while Amgen's shares increased by 2.20% to $434.30. https://openbell.ai/news/MS:1792514936454 2026-10-20T16:48:56.454Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/London--United-Kingdom---February-26--20.jpg?width=250&height=187 Morgan Stanley's Mike Wilson Says Market Correction Nearly Over, Sees S&P 500 Hitting 8,500 Mike Wilson, chief U.S. equity strategist at Morgan Stanley, predicts that the market correction is nearing its end, with the S&P 500 potentially reaching 8,500 by mid-2027, representing a 10.5% increase from its recent close of 7,690.73. He anticipates a few more weeks of volatility before a stronger market finish in 2026. Wilson also noted that over half of Russell 3000 stocks have dropped at least 20% since June, indicating a broader market correction despite a 12% gain in the S&P 500 this year. https://openbell.ai/news/QGEN:1792514921997 2026-10-20T16:48:41.997Z daily 0.9 https://cdn.brandfetch.io/QGEN/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'EQT Is in Advanced Talks to Buy Testing Firm Qiagen' - Bloomberg EQT is currently in advanced negotiations to acquire Qiagen, a testing firm. The potential acquisition could significantly impact both companies, although specific financial details and terms of the deal have not been disclosed. Qiagen's stock ticker is QGEN. https://openbell.ai/news/SAIQ:1792514809241 2026-10-20T16:46:49.241Z daily 0.9 https://cdn.brandfetch.io/SAIQ/w/400/h/400?c=1idopYfmtR7ZKg8QMud WISeSat.Space Holdings shares are trading higher after the company announced it and FOSSA intend to pursue more systematic and demanding in-orbit testing protocols for SEALSQ security technologies, openbell Financial News https://openbell.ai/news/EQNR:1792514779459 2026-10-20T16:46:19.459Z daily 0.9 https://cdn.brandfetch.io/EQNR/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Government expected to approve Jackdaw gas field on Wednesday' - Politico The government is anticipated to approve the Jackdaw gas field on Wednesday, which is expected to have significant implications for energy production. This approval could positively impact Equinor (EQNR), the company involved in the project. The decision is part of broader efforts to enhance domestic energy resources amid ongoing market demands. https://openbell.ai/news/MSTR:1792514771252 2026-10-20T16:46:11.252Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/A-Cartoon-Image-Of-Michael-Saylor-Holdin.jpg?width=250&height=187 Michael Saylor Says Bitcoin's Next Bull Run Has Begun Michael Saylor, Executive Chairman of Strategy (NASDAQ: MSTR), predicts that Bitcoin (CRYPTO: BTC) is entering a new four-year bull market, with potential to reach $100,000 within 12 months. He cites three catalysts for this growth: increasing digital credit issuance, banks offering BTC-backed lending, and the expansion of tokenized securities. Strategy currently holds approximately 845,000 Bitcoin valued at $70 billion to $72 billion and expects 20% to 30% annual growth through digital credit expansion. Saylor also believes that regulatory changes could unlock significant value in the cryptocurrency market. https://openbell.ai/news/KSCP:1792514661945 2026-10-20T16:44:21.945Z daily 0.9 https://cdn.brandfetch.io/KSCP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Knightscope shares are trading higher after the company reported preliminary Q3 revenue growth of $177% year over year. openbell Financial News https://openbell.ai/news/LION:1792514593868 2026-10-20T16:43:13.868Z daily 0.9 https://cdn.brandfetch.io/LION/w/400/h/400?c=1idopYfmtR7ZKg8QMud Legendary Revives Lionsgate Takeover Talks, Submits Offer Legendary Entertainment has revived discussions regarding a potential takeover of Lionsgate, submitting a formal offer for the company. This move comes as Lionsgate seeks to enhance its strategic position in the entertainment industry. The outcome of these negotiations could significantly impact Lionsgate's market valuation and future direction. https://openbell.ai/news/INTU:1792514534833 2026-10-20T16:42:14.833Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/New-York-City--New-York---October-7-2025.jpg?width=250&height=187 What's Going On With Intuit Stock Tuesday? Intuit Inc. (NASDAQ: INTU) stock rose 3.05% to $335.56, outperforming the broader technology sector, as it shows signs of recovering from a downtrend. The company launched Credit Karma Tax, which offers free federal tax filing and a flat $15 fee for state returns, utilizing AI tools for tax preparation. Analysts expect Intuit's upcoming earnings report on November 19 to show a revenue increase to $4.31 billion, despite a projected decline in earnings per share to $2.65. The stock carries a consensus Buy rating with an average price target of $378. https://openbell.ai/news/TSLA:1792514521829 2026-10-20T16:42:01.829Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/Kaunas--Lithuania-2022---April-14-Tesla-.jpg?width=250&height=187 Tesla Analyst Raises Revenues Estimates Ahead Of Q3 Results Tesla Inc (NASDAQ: TSLA) shares increased by 1.47% to $373.46 ahead of its Q3 earnings report. Cantor Fitzgerald raised its revenue estimate for the quarter to approximately $27.9 billion, up from $24.3 billion, while the analyst expects non-GAAP diluted earnings of 47 cents per share, surpassing the consensus of 45 cents. Additionally, Tesla delivered 486,532 vehicles in Q3, exceeding the consensus estimate of 461,974 units, although production fell short of expectations. https://openbell.ai/news/ADDYY:1792514494130 2026-10-20T16:41:34.130Z daily 0.9 https://cdn.brandfetch.io/ADDYY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Adidas Q3 Reports Sales €7.252B, Up 9% YoY; Operating Profit Rises 37%; Expects Full-Year Operating Profit Of ~€2.50B; Receives Majority Of U.S. Tariff Claims With €200M Refund Adidas reported third-quarter sales of €7.252 billion, marking a 9% year-over-year increase, while operating profit surged by 37%. The company anticipates a full-year operating profit of approximately €2.50 billion. Additionally, Adidas has received a majority of its U.S. tariff claims, resulting in a €200 million refund. https://openbell.ai/news/DRTS:1792514343542 2026-10-20T16:39:03.542Z daily 0.9 https://cdn.brandfetch.io/DRTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $16 Price Target HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Alpha Tau Medical (NASDAQ: DRTS) and maintained a price target of $16 for the stock. https://openbell.ai/news/SOFI:1792514317599 2026-10-20T16:38:37.599Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/San-Francisco--Ca--Usa---May-1--2022-Sof.jpg?width=250&height=187 Why Is SoFi Stock Surging on Tuesday? SoFi Technologies Inc (NASDAQ: SOFI) stock surged 3.77% to $14.84 on Tuesday as investors positioned themselves ahead of the company's third-quarter earnings report scheduled for October 27. Analysts expect earnings per share of 17 cents and revenue of approximately $1.26 billion, an increase from $950 million a year ago. The stock currently has a price-to-earnings ratio of 29.2 and an average price forecast of $20, indicating a potential upside of 32.1%. Despite the recent gains, SoFi remains 4.6% below its 20-day SMA and 18.6% below its 200-day SMA. https://openbell.ai/news/WAT:1792514296525 2026-10-20T16:38:16.525Z daily 0.9 https://cdn.brandfetch.io/WAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Live On CNBC, Josh Brown Hosts Segment Titled "Josh's Best Stocks In The Market: Waters" openbell Financial News https://openbell.ai/news/MU:1792514278376 2026-10-20T16:37:58.376Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/Micron.jpg?width=250&height=187 Micron Stock Moves Higher: What's Going On? Micron Technology Inc (NASDAQ: MU) shares rose 0.97% to $913.65, supported by Cantor Fitzgerald's Overweight rating and a price target of $2,000. The firm highlighted ongoing supply shortages and higher-priced contracts, with Micron's recent agreements potentially contributing to 50% of its revenue. Additionally, a $35 billion share repurchase program is set to begin on December 9, which could further boost the stock's performance. https://openbell.ai/news/MOBI:1792514250876 2026-10-20T16:37:30.876Z daily 0.9 https://cdn.brandfetch.io/MOBI/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Reiterates Buy on Mobia Medical, Maintains $19 Price Target BTIG analyst Ryan Zimmerman has reiterated a 'Buy' rating on Mobia Medical (NASDAQ: MOBI) and maintained a price target of $19 for the stock. https://openbell.ai/news/MYGN:1792514226705 2026-10-20T16:37:06.705Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/MA.jpg?width=250&height=187 Myriad Genetics Offloads Struggling Prenatal Unit for $210 Million to Labcorp Labcorp Holdings Inc. has agreed to acquire the prenatal health testing business of Myriad Genetics Inc. for $210 million in an all-cash transaction. The deal includes Myriad's complete prenatal diagnostic testing suite and is expected to generate approximately $160 million in revenue during its first year. Myriad's prenatal business faced challenges, with a 16% year-over-year decline in revenue in the second quarter of 2026, leading to a revision of its 2026 sales guidance from $860-$880 million to $770-$790 million. Myriad's shares rose 35.75% to $5.71 following the announcement.